Skip to main content

Flight Simulator Surgery Market Latest Trends, New Business Opportunity and Growth Prospects to 2023

The Global Flight Simulator Surgery Market size is presumed to expand at 11.6% CAGR during the forecast period (2017-2023) due to the rising expenditure on healthcare, asserts Market Research Future (MRFR).

Competitive Dashboard

The noteworthy players operating the global Flight Simulator Surgery Market are Surgical (U.S.), Virtualincision (U.S.), Hansen Medical (U.S.), Interventional Systems (U.S.), Stryker (U.S.), TransEnterix (U.S.), Corindus Vascular Robots (U.S.), AVRA (U.S.), Titan Medical (Canada), Mazor Robotics (Israel), and others.


Market Overview

Robotic flight stimulator surgery can be referred to as the introduction of virtual reality fundamentals to the robotic-assisted surgery. Designed with several levels of difficulties in surgical procedures, this technology offers a multi-level curriculum. A robotic flight stimulator teaches and enables the surgeons with the required skills to perform robotic surgeries.

Segmental Analysis

The Global Flight Simulator Surgery Market has been segmented on the basis of method, application, end-user, and region.

By mode of application, been segmented into cardiology surgery, general surgery, gynecology, neurosurgery, and others.

By mode of method, been segmented into computer control and direct telemanipulator.

By mode of end-user, been segmented into clinics, hospitals, ambulatory surgical centers, and others.

On the flip side, risk associated with robotic surgeries and high price of surgical robots are restraining the growth of the market during the assessment period. Moreover, the training required for robotic flight stimulator surgery can take away the time required to perform other surgeries which act as a major drawback.

Intended Audience
  • Pharmaceutical Companies
  • Biotechnological Institutes
  • Government and Private Laboratories
  • Research and Development (R&D) Companies
  • Medical Research Laboratories
  • Market Research and Consulting Service Providers
Industry Updates

August 15, 2018: A London-based FundamentalVR, which makes simulation technology for medical training, is launching a new surgical flight simulator. By employing advanced haptics to mimic the real-life sensations of a number of surgical tools, the company has expected the training experience to feel less like a game and more like a real-life surgical scenario.


About Market Research Future: MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:
Market Research Future
Labels:

Comments

Post a Comment

Popular posts from this blog

Immunoassay Analyzers Market By Methods, Technologies, Clinical Review and Industry Outlook

  Immunoassay Analyzers Market  Research Report By Instruments (Immunofluorescence, Chemiluminescence, ELISA, Radioimmunoassay), Application (Infectious Diseases, Autoimmune Diseases, AIDS), End Users (Hospitals)- Global Forecast till 2023 Market Scenario Immunoassay analyzer is a device which measures the presence and concentration of proteins in analyte samples. These instruments are mostly used by pharmaceutical & biotechnological companies, laboratories, and research institutes. The global immunoassay analyzer market is driven by an increasing number of pharmaceutical and biotechnological companies, rising prevalence of different life-threatening diseases, and government’s initiatives for research & development activities. Furthermore, rapid development in diagnostic medical devices, increasing need for better drug treatment, and the increasing geriatric population had also fueled the market’s growth. On the other hand, high cost of instruments and poor reimburseme...
Post a Comment
Read more

Laser Therapy Market Top Company Profiles, Latest Technology, Global Size, Industry Trends

  Laser Therapy Market  Research Report, By Type (Diode Lasers, Solid State Lasers, Gas Lasers, Dye Lasers, and others), By Application (Dermatology and Aesthetics, Surgery, Dental, Urology, Ophthalmology, and others) - Global Forecast from 2017 to 2023 Market Overview: Market Research Future (MRFR) anticipates strong CAGR of 9.2% in the global laser therapy market over the forecast period of 2017-2023. The expansion of the global laser therapy is the result of various market dynamics, out of which, the surging prevalence of diseases such as cataract and arthritis bears profound weightage. Laser therapy is the standard line of treatment in cases of cataract. Laser-based ophthalmology is highly preferred over other methods of treatment. YAG LASER, excimer LASER, femtosecond LASER, and others are the most commonly used lasers in ophthalmology. The widespread prevalence of cataract, as well as arthritis, promote the growth of the global laser therapy market. Expanding base of old...
Post a Comment
Read more

Nonallergic Rhinitis Market Data, Technology Treatment and Diagnosis Management Overview

  Nonallergic Rhinitis Market  Share, Growth And Trends Analysis By Diagnosis (Physical Examination, Allergy Testing, And Imaging Test), By Treatment (Nasal Sprays, Nsaids), And By End User (Hospitals &, Clinics, Research Centers) - Global Forecast Till 2023 Market Highlights Nonallergic rhinitis, also known as vasomotor rhinitis is a medical condition that refers to a set of symptoms that resemble nasal allergies and hayfever (allergic rhinitis) occurring without a known cause. Some of the symptoms of non-allergic rhinitis include Postnasal drip, Runny nose, Sneezing, and Stuffy nose among others. Some patients with nonallergic rhinitis may even develop allergies and asthma eventually, hence treating the condition well in time becomes essential. Industry, Innovation & Related News November 08, 2018 – AstraZeneca Plc. (the UK), a multinational pharmaceutical and biopharmaceutical company announced the sale of its rights for asthma drug Alvesco (ciclesonide), nasal spra...
Post a Comment
Read more